A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients
- PMID: 2350535
- PMCID: PMC1380158
- DOI: 10.1111/j.1365-2125.1990.tb03682.x
A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients
Abstract
Using an open substitution study design, conventional carbamazepine (Tegretol, CBZ-C and a chewable carbamazepine formulation (Tegretol Chewtabs, CBZ-CHEW) were compared in 12 patients with severe intractable epilepsy. During a dosing interval, no significant differences were observed with respect to trough or peak serum concentrations of CBZ and CBZ-10,11-epoxide (CBZ-E), the active metabolite. The area under the serum CBZ concentration-time curve for a dosing interval was (mean +/- s.e. mean) 146 +/- 10 mumols l-1 h on CBZ-C and 143 +/- 9 mumols l-1 h on CBZ-CHEW. The two formulations, therefore, have a similar pharmacokinetic profile and could be used interchangeably in the management of patients with epilepsy.
Similar articles
-
The efficacy and tolerability of chewable carbamazepine compared to conventional carbamazepine in patients with epilepsy.Epilepsy Res. 1990 Apr;5(3):235-9. doi: 10.1016/0920-1211(90)90044-v. Epilepsy Res. 1990. PMID: 2384079
-
The pharmacology of chewable versus regular carbamazepine in chronically treated children with epilepsy.Can J Neurol Sci. 1992 May;19(2):204-7. Can J Neurol Sci. 1992. PMID: 1623447
-
Comparative pharmacokinetic study of chewable and conventional carbamazepine in children.Epilepsia. 1993 Jan-Feb;34(1):158-60. doi: 10.1111/j.1528-1157.1993.tb02390.x. Epilepsia. 1993. PMID: 8422850 Clinical Trial.
-
Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients.Br J Clin Pharmacol. 1993 Sep;36(3):257-61. doi: 10.1111/j.1365-2125.1993.tb04226.x. Br J Clin Pharmacol. 1993. PMID: 9114913 Free PMC article. Clinical Trial.
-
Carbamazepine-induced systemic lupus erythematosus-like disease.Intern Med. 1992 Nov;31(11):1303-5. doi: 10.2169/internalmedicine.31.1303. Intern Med. 1992. PMID: 1295628 Review.
Cited by
-
Impact of generic substitution of anticonvulsants on the treatment of epilepsy.CNS Drugs. 1997 Aug;8(2):124-33. doi: 10.2165/00023210-199708020-00004. CNS Drugs. 1997. PMID: 23338217
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical